Evaluation of Novel Topical Camel Whey Protein Gel for the Treatment of Recurrent Aphthous Stomatitis: Randomised Clinical Study

Status: Completed
Location: See all (2) locations...
Intervention Type: Combination product
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Higher prevalence of recurrent aphthous ulcer in young adults and the severity decreased with increasing age. The etiology of aphthous ulcer remains unclear. Other possible factors include trauma, drug use, deficiency in vitamin B12, folic acid, iron, stress, hormonal changes and metabolic diseases. Many topical agents such as local and systemic an- tibiotics, local antiseptics, topical NSAIDs, and topical corticosteroids are generally prescribed for symptomatic relief. Several approved drug for- mulations such as pills, mouthwash, sprays and paste such as vitamin B12, chlorhexidine mouthwash, steroid lozenges and local anesthetics are primarily suggested for the treatment of aphthous ulcer. Camel whey protein gel was fabricated to get benefits of its antiinflammatory, immunomodulator, Antibacterial and antioxidant effects.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 50
Healthy Volunteers: t
View:

• clinical examination and confirmed history of recurrent oral ulcer,

• recurrence of the oral ulceration

• patients in good condition with no serious systemic disease.

Locations
Other Locations
Egypt
oral medicine and periodontology outpatient clinic, faculty of dentistry, kafrelsheikh University
Kafr Ash Shaykh
Walid Elamrousy
Kafr Ash Shaykh
Time Frame
Start Date: 2021-05-15
Completion Date: 2021-11-30
Participants
Target number of participants: 20
Treatments
Placebo_comparator: placebo gel
Methylcellulose gel was applied to the ulcer till complete healing
Experimental: camel whey protein gel
camel whey protein dissolved in methycellulose gel was applied to the ulcer till complete healing
Authors
dalia rasheed
Related Therapeutic Areas
Sponsors
Leads: Kafrelsheikh University

This content was sourced from clinicaltrials.gov